Context for presentation: current enforcement priorities of relevant agencies (DOJ, OIG, FDA, CMS, MFCUs, State AGs) Landscape of traditional sources of compliance guidance, with focus on OIG's occasional formal publications in the Federal Register Examples of enhanced provisions in Corporate Integrity Agreements that cut across provider types and discussion of why these provisions are as important as the more formal compliance guidance